When gum recession exposes tooth roots, you need a treatment backed by decades of clinical evidence — not marketing hype. As a board-certified periodontist, Dr. Chanook David Ahn reviews the peer-reviewed research to help you make an informed decision about your gum recession treatment.
Gum recession is a progressive condition in which the gingival tissue that normally covers and protects the tooth roots gradually pulls away, exposing the underlying root surface. This is not merely a cosmetic concern. When the root surface becomes exposed, it creates a cascade of clinical problems that worsen over time without appropriate treatment. Understanding the causes of recession and the consequences of leaving it untreated is the essential first step in choosing the right treatment approach.
The causes of gum recession are varied and often interconnected. Aggressive tooth brushing with a hard-bristled brush or excessive force is one of the most common causes, gradually wearing away the thin gingival tissue on the facial surfaces of teeth. Periodontal disease, an inflammatory condition caused by bacterial plaque accumulation, destroys the connective tissue attachment and supporting bone around teeth, leading to recession as the tissue loses its structural foundation. Patients with a thin gingival biotype — a genetic trait characterized by thin, translucent gum tissue — are particularly vulnerable to recession because the tissue lacks the thickness to withstand mechanical forces or inflammatory insult.
Orthodontic tooth movement, particularly when teeth are moved outside the bony housing of the alveolar ridge, can precipitate recession by thinning the tissue and bone on the facial aspect. Bruxism and clenching habits generate lateral forces on teeth that can contribute to tissue breakdown at the gumline. Tobacco use impairs blood flow to the gingival tissues, reducing their ability to resist and recover from injury. Even the position of the frenum — the small fold of tissue connecting the lip or cheek to the gum — can exert tension on the gingival margin and contribute to progressive recession.
The consequences of untreated gum recession extend far beyond appearance. Exposed root surfaces are not covered by the hard, protective enamel that shields the crown of the tooth. The root surface is composed of cementum and dentin, which are softer, more porous, and far more susceptible to decay and sensitivity. Patients with exposed roots commonly experience sharp, shooting pain when drinking cold beverages, eating acidic foods, or even breathing cold air. Root surface caries can develop rapidly on these exposed surfaces and are more difficult to treat than coronal cavities.
Perhaps most importantly, gum recession is a progressive condition. Without intervention, the tissue continues to recede, exposing more root surface, leading to further bone loss, and eventually compromising the stability of the tooth itself. The attachment apparatus that holds a tooth in the jawbone — the periodontal ligament, cementum, and alveolar bone — depends on healthy overlying gingival tissue for its protection and maintenance. When that tissue is lost, the supporting structures are exposed to bacterial invasion and mechanical trauma, setting in motion a cycle of accelerating destruction.
This is precisely why choosing an evidence-based treatment for gum recession matters so much. The treatment you select today will determine the health and stability of those teeth for decades to come. A technique that produces impressive short-term results but fails to provide lasting stability is not a sound investment in your long-term oral health. The treatment decision should be guided by peer-reviewed clinical evidence — the same standard applied in every other field of medicine — not by proprietary marketing claims or anecdotal before-and-after photographs.
The subepithelial connective tissue graft, commonly referred to as CTG or SCTG, is a surgical procedure in which a small piece of connective tissue is harvested from the patient's own palate and transplanted to the site of gum recession. The harvested tissue — an autogenous graft, meaning it comes from the patient's own body — is placed over the exposed root surface and secured beneath a coronally advanced flap of existing gum tissue. This dual-layer approach provides the exposed root with a biological covering of living tissue that integrates with the surrounding gingiva, thickens the tissue permanently, and promotes the growth of keratinized tissue at the gumline.
The term "gold standard" is not a marketing designation or a casual endorsement. In evidence-based medicine, the gold standard is the technique against which all other approaches are measured — the one with the strongest, most consistent body of evidence supporting its use. The connective tissue graft has earned this designation through decades of rigorous scientific evaluation across hundreds of independent studies conducted at dental schools and research institutions worldwide.
Chambrone and colleagues published a landmark systematic review in the Journal of Dentistry in 2008, establishing the subepithelial connective tissue graft as the gold standard for root coverage procedures. This was not a single study but a comprehensive analysis of the cumulative evidence, and it confirmed that CTG-based procedures produced superior root coverage outcomes compared to all other available techniques. The American Academy of Periodontology Regeneration Workshop in 2015 further affirmed this position, concluding that SCTG provides "the best root coverage outcomes" among all available surgical approaches. The 10th European Workshop on Periodontology in 2014 conducted its own independent review of the evidence and reached the same conclusion: connective tissue grafting delivers the best outcomes for root coverage.
The advantages of using the patient's own connective tissue are rooted in basic biology. Autogenous tissue is 100 percent biocompatible — there is no risk of immune rejection, foreign body reaction, or allergic response because the graft material is the patient's own living tissue. When placed at the recipient site, the connective tissue graft maintains its vitality by establishing a blood supply from the surrounding tissues within the first 48 to 72 hours. This living graft does not undergo the remodeling and resorption that affects processed biomaterials; instead, it integrates with the native tissue and becomes a permanent addition to the gingival architecture.
One of the most clinically significant advantages of connective tissue grafting is its ability to increase keratinized tissue width at the treatment site. Keratinized tissue is the tough, dense, coral-pink tissue that forms the attached gingiva around healthy teeth. This tissue serves as a protective barrier against mechanical trauma, bacterial infiltration, and inflammatory breakdown. When a patient has inadequate keratinized tissue — a condition that often accompanies recession — the remaining tissue is fragile, mobile, and vulnerable to further recession. Connective tissue grafting addresses this problem directly by building new keratinized tissue at the site, creating a more resilient protective barrier that resists future breakdown.
Connective tissue grafting also increases tissue thickness at the graft site permanently. The additional tissue volume creates a thicker gingival biotype that is inherently more resistant to recession recurrence. This increase in tissue thickness is not a temporary effect that fades as the graft remodels; it persists for years and decades, as confirmed by long-term follow-up studies.
Long-Term Evidence for Connective Tissue Grafts:
Bertoldi et al. (2024), Journal of Clinical Periodontology: In the longest follow-up study ever published on connective tissue grafts, researchers followed 102 subjects for 21 to 30 years (mean 27 years). Root coverage was 95.2% at one year and remained at 81.7% at the final follow-up — demonstrating remarkable stability across nearly three decades.
Barootchi et al. (2019), Journal of Clinical Periodontology: A 12-year follow-up study documented 74.5% root coverage maintained at the 12-year mark, confirming that CTG results remain clinically meaningful well beyond the initial healing period.
Rasperini et al. (2018): This study estimated approximately 70% probability of maintaining complete root coverage over a 9-year period, providing patients with realistic expectations about long-term outcomes.
Tavelli et al. (2019), Journal of Dental Research: A network meta-analysis of 60 randomized controlled trials concluded that only CTG-based procedures maintained gingival margin stability over time — meaning that among all techniques studied, only those incorporating connective tissue grafts prevented the treated gum margin from drifting back toward recession over the long term.
These findings are not isolated results from a single research group. They represent the consensus of independent investigators across multiple countries, using different study designs, over different time periods, all arriving at the same conclusion: connective tissue grafting provides the most predictable, most durable, and best-documented outcomes for gum recession treatment.
One of the most common concerns patients express about gum grafting is the fear of discomfort during and after the procedure. Dr. Ahn addresses this concern directly by offering IV conscious sedation for all gum grafting procedures at The Loft Dental Studio. IV sedation represents the deepest level of office-based sedation available, and it transforms what many patients anticipate as a stressful experience into one they describe as surprisingly comfortable.
IV conscious sedation works by delivering sedative medication directly into the bloodstream through an intravenous line, typically placed in the hand or arm. Because the medication bypasses the digestive system entirely, its onset is virtually immediate — patients begin to feel deeply relaxed within seconds of administration. The patient remains conscious throughout the procedure, able to respond to verbal instructions and maintain protective reflexes, but experiences a profound sense of calm and detachment from the surgical environment. One of the most valued effects of IV sedation is anterograde amnesia: most patients remember little to nothing about the procedure itself, even though they were responsive during it.
The precision of IV sedation is a significant advantage over alternative sedation methods. With nitrous oxide (laughing gas), the level of relaxation achieved is mild and may be insufficient for patients with moderate to severe anxiety or for longer procedures. Oral sedation — taking a pill before the appointment — is limited by unpredictable absorption from the gastrointestinal tract, meaning the depth and timing of sedation cannot be precisely controlled. IV sedation allows Dr. Ahn to titrate the dosage in real time, adjusting the medication throughout the procedure to maintain the optimal level of comfort. If the patient shows any sign of awareness or discomfort, the medication can be increased immediately. If the procedure is finishing and lighter sedation is appropriate, the dosage can be reduced.
This real-time titration capability also makes IV sedation particularly beneficial for patients who need multiple recession sites treated in a single visit. Rather than scheduling separate procedures weeks apart, multiple grafts can be completed in one session while the patient rests comfortably under sedation. This approach reduces the total number of healing periods, the total number of office visits, and the overall duration of treatment.
Patient monitoring during IV sedation at The Loft Dental Studio follows hospital-grade protocols. Continuous pulse oximetry tracks blood oxygen saturation, capnography monitors exhaled carbon dioxide levels to confirm adequate breathing, and blood pressure is measured at regular intervals throughout the procedure. Supplemental oxygen is provided via nasal cannula, and reversal agents are immediately available in the rare event they are needed. This level of monitoring ensures the highest standard of safety during sedation.
Recovery from IV sedation is straightforward. Patients rest in the office for one to two hours after the procedure until the effects of the medication have diminished sufficiently. A responsible adult driver is required to transport the patient home, and patients should plan to rest for the remainder of the day. No overnight hospital stay is necessary. Many patients tell us their gum grafting with IV sedation was far more comfortable than they expected — some say they would have done it years earlier if they had known how manageable the experience would be.
The Pinhole Surgical Technique, commonly abbreviated as PST, is a marketed surgical approach to gum recession treatment in which the gum tissue is repositioned through a small puncture hole made with a needle, using specially designed instruments to loosen and advance the tissue coronally over the exposed root surface. Collagen membrane strips are then placed underneath the repositioned tissue to stabilize it in the new position during healing.
PST was developed and patented by Dr. John Chao, a dentist in Alhambra, California. The technique is protected by United States patents and the name "Pinhole Surgical Technique" is a registered trademark. To perform PST, a dentist must complete a mandatory certification course costing between $5,500 and $7,500 and purchase proprietary instruments that cost approximately $4,000. These certification and instrumentation requirements mean that only practitioners who have invested in the Chao Pinhole Academy program can legally market themselves as performing the Pinhole Surgical Technique.
The marketing claims associated with PST are compelling to patients: no incisions, no sutures, immediate cosmetic improvement, faster healing, and the ability to treat multiple teeth in a single visit. These claims describe legitimate features of the technique's approach — the procedure is indeed less invasive in terms of surgical access, and the immediate post-operative appearance can be impressive because the tissue has been physically repositioned to cover the exposed roots.
However, the critical question for any medical or dental procedure is not what it claims to accomplish, but what the independent, peer-reviewed evidence actually demonstrates about its outcomes — particularly its long-term outcomes. Marketing claims and clinical evidence are two different things, and patients making treatment decisions that will affect their oral health for decades deserve to see both sides of the comparison.
When evaluating any medical or dental technique, the hierarchy of evidence matters. At the top of that hierarchy sit randomized controlled trials (RCTs) and systematic reviews of RCTs — study designs that minimize bias and provide the most reliable evidence for clinical decision-making. Case series and case reports, while useful for generating hypotheses and demonstrating feasibility, sit lower on the evidence hierarchy because they lack control groups, randomization, and blinding, making them susceptible to selection bias and reporting bias.
With that framework in mind, the following comparison presents what the published evidence actually shows when connective tissue grafting and the Pinhole Surgical Technique are evaluated side by side.
The comparison grid above reveals several important findings. In the only head-to-head RCT, connective tissue grafting and PST produced statistically similar root coverage at one year. Neither technique demonstrated a clear superiority in terms of total root coverage in this single trial. However, the clinically meaningful differences emerge in the secondary outcomes — keratinized tissue gain and tissue thickness — both of which were significantly better with connective tissue grafting.
The keratinized tissue finding is particularly important. Keratinized tissue is the tough, protective gingiva that shields the tooth and underlying bone from mechanical and bacterial insult. A procedure that fails to build meaningful keratinized tissue at the treatment site leaves the patient vulnerable to future recession recurrence, even if the initial root coverage appears adequate. The fact that CTG achieved statistically significant keratinized tissue gain (P=0.002) while PST did not reach statistical significance represents a clinically relevant advantage for long-term tissue stability.
Important Context: The only randomized controlled trial (RCT) comparing PST to CTG — Shibly et al. (2025) published in the Compendium of Continuing Education in Dentistry — found no significant difference in root coverage at one year. However, Dr. John Chao, the patent holder and developer of PST, was a co-author on this study. The RCT results (63.6% mean root coverage for PST) were dramatically lower than Chao's original 2012 case series claims (94% root coverage), raising important questions about the performance gap between controlled research settings and the inventor's own selected cases.
The long-term stability data also warrants careful examination. The 86.6% root coverage reported for PST at 14.5 years comes from a case series published by the inventor — not a randomized controlled trial with independent investigators. Case series are inherently susceptible to selection bias, as the clinician can choose which cases to include and which to exclude from the report. The long-term data for connective tissue grafting, by contrast, comes from independent research groups conducting formal follow-up studies with defined inclusion criteria and standardized measurement protocols.
None of this means that PST is without merit or that it cannot produce acceptable clinical results. The technique does offer genuine advantages in terms of reduced surgical invasiveness and potentially faster initial recovery. However, when making a decision about which technique to entrust with the long-term health of your gums and teeth, the depth, independence, and consistency of the evidence base matters enormously. In that comparison, connective tissue grafting has an overwhelming advantage.
The fundamental biological difference between connective tissue grafting and the Pinhole Surgical Technique lies in the material that provides long-term support to the repositioned tissue. CTG uses the patient's own living connective tissue — autogenous tissue that integrates permanently with the recipient site. PST relies on collagen membrane strips, typically acellular dermal matrix (AlloDerm) or similar allograft materials derived from processed cadaver tissue or animal collagen. This distinction has profound implications for long-term outcomes.
Allograft materials like AlloDerm undergo a biological process called remodeling after placement. The host body gradually breaks down the implanted material and replaces it with native tissue. In theory, this remodeling process should result in tissue that is functionally equivalent to autogenous tissue. In practice, however, the published evidence consistently shows that the remodeling process leads to progressive volume loss and tissue thinning over time — a phenomenon that does not occur with autogenous connective tissue grafts.
The clinical evidence documenting this regression is substantial. Harris published a study in the Journal of Periodontology in 2004 that followed AlloDerm root coverage procedures over 48 months. Root coverage dropped from 93.4% at the initial assessment to just 65.8% at the 48-month follow-up. Perhaps more concerning, only 32% of treated sites remained stable over this period, meaning that the majority of sites experienced clinically significant regression as the allograft material remodeled.
Moslemi and colleagues published a five-year split-mouth randomized controlled trial in the Journal of Clinical Periodontology in 2011 that provided particularly compelling evidence. In a split-mouth design, the same patient receives one technique on one side of the mouth and the comparison technique on the other side, eliminating patient-level variables as confounders. The findings were striking: tissue thickness gains achieved with AlloDerm returned to pre-surgical values by five years, while tissue thickness gains achieved with connective tissue grafts remained stable. This means that whatever volume the AlloDerm initially added was eventually lost through remodeling, while the patient's own connective tissue persisted indefinitely.
Barootchi and colleagues confirmed this pattern in a nine-year follow-up study published in the Journal of Periodontology in 2021. AlloDerm root coverage declined from 77% to 62% over nine years, a statistically significant reduction (P<0.05). The tissue that appeared adequate in the early post-operative period progressively thinned and receded as the allograft material was resorbed and replaced by host tissue of lesser volume.
Zhang and colleagues published a meta-analysis of 24 randomized controlled trials in the Annals of Palliative Medicine in 2022 that quantified the widening advantage of CTG over AlloDerm over time. At six months, the difference in keratinized tissue width between CTG and AlloDerm was -0.29 millimeters. Beyond 12 months, that difference widened to -0.78 millimeters. In other words, the superiority of connective tissue grafting for keratinized tissue generation becomes more pronounced with each passing year — a pattern that reflects the ongoing remodeling and resorption of the allograft material.
The bottom line: Biomaterials can provide acceptable short-term results, but autogenous connective tissue from your own body remains stable for decades. When you are investing in gum recession treatment, the five-year and ten-year outcomes matter more than the first week. A procedure that looks good at the one-month follow-up but progressively regresses over the following years is not providing the lasting value that patients expect and deserve.
Choosing a gum recession treatment is a significant healthcare decision that will affect the health and appearance of your smile for years to come. The following questions are designed to help you evaluate any treatment option — and any provider — using the same evidence-based framework that guides decisions in every other area of medicine. Bring these questions to your consultation and pay close attention to the specificity and transparency of the answers you receive.
These questions are not designed to steer you toward or away from any particular technique. They are designed to ensure that your treatment decision is based on transparent, verifiable evidence rather than marketing materials or testimonials. Any qualified provider should be comfortable answering every one of these questions with specific, evidence-based information.
Gum recession treatment is a specialized surgical procedure that requires advanced training, refined technique, and a deep understanding of periodontal biology. The provider you choose matters as much as the technique itself. Dr. Chanook David Ahn brings a combination of credentials, training, and clinical philosophy that patients consistently cite as their reasons for choosing The Loft Dental Studio for their gum grafting care.
Dr. Ahn is a Diplomate of the American Board of Periodontology, a distinction earned by fewer than 40 percent of practicing periodontists in the United States. Board certification requires passing comprehensive written and oral examinations that test mastery of periodontal medicine, surgical technique, implantology, and regenerative procedures beyond what is required for a specialty license alone. This certification represents the highest standard of professional competence recognized in the field of periodontics.
Dr. Ahn completed his periodontal residency at Yale-New Haven Hospital, one of the most selective and rigorous residency programs in the country. During his residency, he served as Chief Resident and was recognized as Resident of the Year. His training at Yale emphasized evidence-based treatment planning, microsurgical technique, and regenerative periodontal therapy — the same principles that guide his clinical practice today.
In addition to his private practice, Dr. Ahn serves as clinical faculty at the UCLA School of Dentistry, where he teaches the next generation of dental professionals. This academic appointment reflects his standing in the periodontal community and keeps him directly connected to the latest research, teaching methods, and clinical innovations in the field.
Dr. Ahn's approach to gum recession treatment is guided by the published evidence, not by proprietary marketing programs or manufacturer relationships. He recommends connective tissue grafting because the independent, peer-reviewed literature consistently demonstrates that it provides the most predictable and durable outcomes. When a different approach is warranted by the clinical situation, he discusses the evidence for that approach with equal transparency.
As described in detail above, Dr. Ahn offers IV conscious sedation for all gum grafting procedures. This level of sedation ensures that patients are deeply relaxed throughout the procedure, experience minimal to no discomfort, and remember little of the surgical experience afterward. Hospital-grade monitoring is maintained throughout the sedation.
Dr. Ahn incorporates Platelet-Rich Fibrin (PRF) therapy into his gum grafting protocol. PRF is prepared from a small sample of the patient's own blood, which is centrifuged to concentrate platelets, growth factors, and fibrin into a bioactive membrane. When placed at the surgical site, PRF accelerates tissue healing, reduces post-operative inflammation, and promotes the formation of new blood vessels in the grafted tissue. Because PRF is derived from the patient's own blood, it carries no risk of immune reaction or disease transmission.
Dr. Ahn performs connective tissue grafts using microsurgical instrumentation and technique, which involves smaller incisions, finer suture materials, and greater precision than standard surgical approaches. Microsurgical gum grafting results in less tissue trauma, faster healing, reduced post-operative discomfort, and improved aesthetic outcomes with minimal visible scarring.
The Loft Dental Studio accepts most major PPO dental insurance plans, including Delta Dental, Cigna, MetLife, Guardian, Aetna, United Healthcare, and Blue Cross Blue Shield. The administrative team verifies your benefits before treatment so you understand your coverage and out-of-pocket costs. For patients who prefer to manage costs over time, CareCredit financing is available with low-interest and interest-free payment plans. FSA and HSA accounts are also accepted.
View before and after photos of gum grafting, dental implants, LANAP laser treatment, and other procedures performed by Dr. Ahn at The Loft Dental Studio.
Dr. Ahn will evaluate your recession, discuss all treatment options honestly, and recommend the approach backed by the strongest clinical evidence for your specific case.
Call (714) 549-7030Or request an appointment online
3151 Airway Ave, Suite F-103, Costa Mesa, CA 92626
At The Loft Dental Studio, the treatment recommendations Dr. Ahn provides are determined by one thing: the best available scientific evidence. Every technique offered in this practice has been validated by independent, peer-reviewed research conducted at accredited dental schools and research institutions. This is not a philosophical preference or a marketing strategy. It is the same standard of evidence-based practice that governs treatment decisions in medicine, surgery, and every other health science discipline.
The periodontal field, like all areas of healthcare, is not immune to marketing-driven trends. Proprietary techniques, branded surgical systems, and patented instrumentation programs create financial incentives that can influence how procedures are promoted, studied, and adopted. When a single individual or company controls the patents, trademarks, certification process, and instrumentation for a technique — and when the majority of the published evidence comes from that same individual — patients and referring dentists should evaluate the claims with an appropriately critical eye.
We believe you deserve treatment decisions based on the best available science — not a branded surgical technique controlled by patents and mandatory certification fees. When the evidence changes, our recommendations change with it. If a newer technique is demonstrated through rigorous, independent research to provide superior long-term outcomes, Dr. Ahn will adopt it. Until that evidence exists, the connective tissue graft remains the gold standard for gum recession treatment, and that is what we recommend for patients whose clinical situation calls for root coverage surgery.
This page presents the published evidence as accurately and fairly as we can. We have cited specific studies, named the journals, identified the study designs, and noted where potential conflicts of interest exist. We encourage you to discuss this information with your own dentist, research the studies cited here, and bring any questions to your consultation. An informed patient is always our best patient.
The only randomized controlled trial comparing PST to CTG — Shibly et al., published in 2025 in the Compendium of Continuing Education in Dentistry — found no significant difference in root coverage at one year. However, connective tissue grafting produced significantly more keratinized tissue (P=0.002) and greater tissue thickness gains than PST in the same trial. Keratinized tissue is the tough, protective gum tissue that guards against future recession recurrence. Long-term follow-up studies overwhelmingly favor CTG for stability and durability, with published data extending to 27 years. PST uses processed collagen membrane rather than the patient's own tissue, and the long-term data for allograft materials shows a consistent pattern of volume loss over time.
The connective tissue graft has earned its gold standard designation through the largest body of peer-reviewed evidence of any gum recession treatment. Hundreds of independent studies from dental schools worldwide have confirmed its effectiveness. The American Academy of Periodontology, the European Workshop on Periodontology, and multiple systematic reviews and meta-analyses have all confirmed SCTG as the technique providing the best root coverage outcomes. CTG delivers the most predictable root coverage, meaningful keratinized tissue gain, and the longest documented success of any recession treatment — up to 27 years in the study by Bertoldi et al. published in the Journal of Clinical Periodontology in 2024.
With IV conscious sedation, most patients experience no discomfort during the procedure and remember little afterward. IV sedation delivers medication directly into the bloodstream, producing deep relaxation while the patient remains conscious and able to respond to verbal instructions. Post-operative soreness is manageable with prescribed medications and typically resolves within seven to ten days. Dr. Ahn also uses PRF (Platelet-Rich Fibrin) therapy, prepared from your own blood, to accelerate healing and reduce post-operative inflammation. Patients consistently report that their experience was far more comfortable than they anticipated.
Connective tissue graft results are documented to remain stable for decades. The longest published follow-up — Bertoldi et al. (2024) in the Journal of Clinical Periodontology — followed 102 subjects for a mean of 27 years and documented 81.7% root coverage maintained at the final assessment. Barootchi et al. (2019) demonstrated 74.5% root coverage maintained at 12 years. This extraordinary long-term durability is unmatched by any alternative technique in the published literature and reflects the biological advantage of using the patient's own living tissue, which integrates permanently rather than undergoing remodeling and resorption.
The Pinhole Surgical Technique (PST) is a patented, trademarked surgical technique developed by Dr. John Chao. The procedure involves making a small puncture hole in the gum tissue, using specially designed instruments to loosen and reposition the tissue over exposed root surfaces, and placing collagen membrane strips underneath the repositioned tissue for stabilization. Performing PST requires completing a mandatory certification course ($5,500 to $7,500) and purchasing proprietary instruments (approximately $4,000). While the technique offers a less invasive surgical approach, its evidence base is limited compared to established grafting techniques, with the majority of published studies conducted by the inventor or his associates rather than by independent research groups.
Yes, most PPO dental insurance plans cover gum grafting as a medically necessary periodontal procedure. Coverage typically ranges from 50 to 80 percent of the allowed amount, depending on your specific plan's periodontal surgery benefits. The Loft Dental Studio accepts Delta Dental, Cigna, MetLife, Guardian, Aetna, United Healthcare, and Blue Cross Blue Shield. The administrative team verifies your specific benefits before treatment begins, so you understand your coverage and out-of-pocket costs in advance. CareCredit financing is also available for patients who prefer to manage costs through monthly payment plans, and FSA/HSA accounts are accepted.
Absolutely. Dr. Ahn offers IV conscious sedation for all gum grafting procedures at The Loft Dental Studio. IV sedation is especially beneficial for patients with dental anxiety, those who need multiple recession sites treated in a single session, or anyone who simply wants to be deeply relaxed during the procedure. The medication is delivered directly into the bloodstream for immediate onset and can be precisely adjusted throughout the procedure. Continuous monitoring includes pulse oximetry, capnography, blood pressure monitoring, and supplemental oxygen. You will need a responsible adult driver to take you home, but no overnight stay is required. Most patients are ready to leave the office within one to two hours after the procedure is completed.